Search Results - "Gukasyan, Jaklin"
-
1
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer
Published in Clinical cancer research (01-12-2022)“…Immune checkpoint inhibitors (ICI) have revolutionized the treatment of non-small cell lung cancer (NSCLC), but predictive biomarkers of their efficacy are…”
Get full text
Journal Article -
2
Mass cytometry reveals classical monocytes, NK cells and ICOS+ CD4+ T cells associated with pembrolizumab efficacy in lung cancer patients
Published in Clinical cancer research (01-12-2022)Get full text
Journal Article -
3
Abstract 6614: Association between immune gene signatures and neoepitopes with electrostatic charge opposite to their HLA-B binding pocket in melanoma (MEL) and lung adenocarcinoma (LUAD)
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract Purpose: Immune checkpoint blockade (ICB) has revolutionized treatment of melanoma and lung cancer. Recent evidence suggests that human leukocyte…”
Get full text
Journal Article -
4
Electrostatic human leukocyte antigen-neoantigen interactions and durable benefit in non-small cell lung cancer patients treated with immunotherapy
Published in Journal of clinical oncology (20-05-2019)“…Abstract only 2635 Background: Human leukocyte antigen (HLA) binding relies on energy from the interaction of B-pocket residues with anchor amino acids (AA)…”
Get full text
Journal Article -
5
Prevalence of human leukocyte antigen-B27 supertype in the context of positively charged neoepitopes and association with PD-L1 as an immune escape mechanism
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3083 Background: Recent evidence suggests efficacy of immune checkpoint blockade may be influenced by human leukocyte antigen (HLA)-B. HLA-B27…”
Get full text
Journal Article -
6
Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC
Published in Lung cancer (Amsterdam, Netherlands) (01-11-2021)“…Abbreviations: ICI; Immune checkpoint inhibitors. γClinically Acted Upon Thyroid Dysfunction is defined as thyroid diagnosis documentation and/or thyroid…”
Get full text
Journal Article -
7
Human leukocyte antigen (HLA) B44 supertype and immunotherapy outcomes in non-small cell lung cancer (NSCLC)
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
8
A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
9
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44
Published in Nature cancer (01-12-2020)“…Human leukocyte antigen (HLA)-B has been recognized as a major determinant of discrepancies in disease outcomes, and recent evidence indicates a role in immune…”
Get full text
Journal Article